Leading science, pioneering therapies
CRM Publications

The Orf18 gene product from conjugative transposon Tn916 is an ArdA antirestriction protein that inhibits type I DNA restriction-modification systems.

TitleThe Orf18 gene product from conjugative transposon Tn916 is an ArdA antirestriction protein that inhibits type I DNA restriction-modification systems.
Publication TypeJournal Article
Year of Publication2008
AuthorsSerfiotis-Mitsa D, Roberts GA, Cooper LP, White JH, Nutley M, Cooper A, Blakely GW, Dryden DTF
JournalJ Mol Biol
Volume383
Issue5
Pagination970-81
Date Published2008 Nov 28
ISSN1089-8638
KeywordsBacterial Proteins, Binding, Competitive, Calorimetry, Differential Scanning, Chromatography, Gel, Chromatography, High Pressure Liquid, Chromosomes, Bacterial, DNA Restriction-Modification Enzymes, DNA Transposable Elements, DNA, Bacterial, Electrophoresis, Polyacrylamide Gel, Enterococcus faecalis, Molecular Weight, Open Reading Frames, Protein Folding, Protein Structure, Secondary, Recombinant Proteins, Site-Specific DNA-Methyltransferase (Adenine-Specific), Spectrometry, Fluorescence, Thermodynamics
Abstract

Gene orf18, which is situated within the intercellular transposition region of the conjugative transposon Tn916 from the bacterial pathogen Enterococcus faecalis, encodes a putative ArdA (alleviation of restriction of DNA A) protein. Conjugative transposons are generally resistant to DNA restriction upon transfer to a new host. ArdA from Tn916 may be responsible for the apparent immunity of the transposon to DNA restriction and modification (R/M) systems and for ensuring that the transposon has a broad host range. The orf18 gene was engineered for overexpression in Escherichia coli, and the recombinant ArdA protein was purified to homogeneity. The protein appears to exist as a dimer at nanomolar concentrations but can form larger assemblies at micromolar concentrations. R/M assays revealed that ArdA can efficiently inhibit R/M by all four major classes of Type I R/M enzymes both in vivo and in vitro. These R/M systems are present in over 50% of sequenced prokaryotic genomes. Our results suggest that ArdA can overcome the restriction barrier following conjugation and so helps increase the spread of antibiotic resistance genes by horizontal gene transfer.

DOI10.1016/j.jmb.2008.06.005
Alternate JournalJ. Mol. Biol.
PubMed ID18838147
Grant ListBB/D001870/1 / / Biotechnology and Biological Sciences Research Council / United Kingdom
GR080463MA / / Wellcome Trust / United Kingdom
Publication institute
Other